Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. But recently, the industry has failed to do its job as it shed 14% over the past six months. This drawdown was worse than the S&P 500’s 6.2% fall. Despite the lackluster result, a few diamonds in the rough can produce earnings growth no matter what, and we started StockStory to help you find them. Keeping that in mind, here is one consumer stock poised to generate sustainable market-beating returns and two we’re steering clear of. Two Consumer Staples Stocks to Sell: Calavo (CVGW) Market Cap: $464.5 million A trailblazer in the avocado industry, Calavo Growers (NASDAQ:CVGW) is a pioneering California-based provider of high-quality avocados and other fresh food products. Why Does CVGW Fall Short? Products have few die-hard fans as sales have declined by 14.7% annually over the last three years Smaller revenue base of $688.3 million means it hasn’t achieved the economies of scale that some industry juggernauts enjoy Gross margin of 10.6% is below its competitors, leaving less money to invest in areas like marketing and production facilities Calavo’s stock price of $25.82 implies a valuation ratio of 15.3x forward P/E. Dive into our free research report to see why there are better opportunities than CVGW. Tilray (TLRY) Market Cap: $432.1 million Founded in 2013, Tilray Brands (NASDAQ:TLRY) engages in cannabis research, cultivation, and distribution, offering a range of medical and recreational cannabis products, hemp-based foods, and alcoholic beverages. Why Should You Sell TLRY? Expenses have increased as a percentage of revenue over the last year as its operating margin fell by 70.1 percentage points Long-term business health is up for debate as its cash burn has increased over the last year Negative returns on capital show management lost money while trying to expand the business, and its decreasing returns suggest its historical profit centers are aging Tilray is trading at $0.43 per share, or 5.5x forward EV-to-EBITDA. If you’re considering TLRY for your portfolio, see our FREE research report to learn more. One Consumer Staples Stock to Buy: Inter Parfums (IPAR) Market Cap: $3.85 billion With licenses to produce colognes and perfumes under brands such as Kate Spade, Van Cleef & Arpels, and Abercrombie & Fitch, Inter Parfums (NASDAQ:IPAR) manufactures and distributes fragrances worldwide. Why Will IPAR Beat the Market? Remarkable 16.3% revenue growth over the last three years demonstrates its ability to capture significant market share Products command premium prices and lead to a top-tier gross margin of 55.6% Free cash flow margin jumped by 11.3 percentage points over the last year, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends Story Continues At $119.71 per share, Inter Parfums trades at 21.6x forward P/E. Is now the right time to buy? See for yourself in our in-depth research report, it’s free. Stocks That Overcame Trump’s 2018 Tariffs Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years. Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like United Rentals (+322% five-year return). Find your next big winner with StockStory today for free. View Comments
1 Consumer Stock with Impressive Fundamentals and 2 to Avoid
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...